Sandi Tenza shares her journey with her son Sanda, diagnosed with haemophilia A, and the urgent need for awareness and ...

CSL Behring Austria today announced that the first haemophilia B patient in Austria was treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at the Comprehensive Care Center of the ...

Dr. Jonathan C. Roberts, associate medical director and research director of the Bleeding and Clotting Disorders Institute in ...

Soleo Health has been named the exclusive in-network specialty pharmacy for Qfitlia (fitusiran) by Sanofi, the first ...

Pfizer on Monday announced it is halting development of a daily weight loss pill after one patient experienced a liver injury ...

Saisei Ventures, a leading venture investment firm focused on advancing Japanese biotechnology and therapeutic innovations, today announced the launch of its Executive Fellows Program, a structured ...

OmniAb, Inc. will report financial results for the three months ended March 31, 2025 after the close of the U.S. financial markets on Thursday, May 8, 2025, and will hold a conference call that same ...

Stephen N. Patrick, a dedicated professional and compassionate community member, passed away on April 11, 2025, at the age of 67. His life was marked by a commitment to family, ca ...

The global gene therapy market is projected to grow at a significant CAGR of 20% from 2024 to 2029. This growth is driven by ...

A somewhat obscure federal program designed to reduce drug prices for health providers is getting scrutiny from lawmakers ...

The Montreal Airport Marriott In-Terminal Hotel was transformed into a luxurious cruise liner for an evening of elegance and celebration. Guests enjoyed an immersive experience featuring gourmet ...